Literature DB >> 29725968

The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort.

Joanne Allen1, Fiona M Alpass2, Christine V Stephens2.   

Abstract

PURPOSE: To compare the predictive validity of two self-reported outcome measures, the Patient-Reported Outcome Measurement Information System (PROMIS) Global Health measure and the 12-item Health Survey (SF-12).
METHODS: Data were obtained from 1286 persons (55% female) aged 61-77 responding to a longitudinal survey. Inter-correlations of the SF-12 and PROMIS physical and mental summary scores were examined. ROC and AUC analyses were conducted to compare mental health score sensitivity to high levels of depression symptoms. Multiple regression was used to assess physical health score sensitivity to adverse health events over 12-month follow-up.
RESULTS: All scores displayed negatively skewed distributions. The respective SF-12 and PROMIS physical (r = .78) and mental (r = .62) health scores displayed strong associations. Mental health scores provided useful discrimination of persons reporting high depression symptoms (AUCSF12 = 0.90; AUCPROMIS = 0.84), although the SF-12 provided better case discrimination. Decreases in physical health over time were associated with recurrent falls (BSF12 = - 1.62; BPROMIS = - 1.14) and hospitalisations (BSF12 = - 1.69; BPROMIS = - 1.11).
CONCLUSIONS: The SF-12 and PROMIS brief measures of physical and mental health assess related but distinct health constructs. However, they display comparable sensitivity to adverse health outcomes. Results from studies utilising the SF-12 and PROMIS global health measures should be compared with sensitivity to differences in the content and scoring of these measures.

Entities:  

Keywords:  CES-D; Health, Work and Retirement study; New Zealand; Older adults; PROMIS; SF-12

Mesh:

Year:  2018        PMID: 29725968     DOI: 10.1007/s11136-018-1871-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  25 in total

1.  Using the SF-36 with older adults: a cross-sectional community-based survey.

Authors:  S J Walters; J F Munro; J E Brazier
Journal:  Age Ageing       Date:  2001-07       Impact factor: 10.668

2.  Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12).

Authors:  Alfredo J Selim; William Rogers; John A Fleishman; Shirley X Qian; Benjamin G Fincke; James A Rothendler; Lewis E Kazis
Journal:  Qual Life Res       Date:  2008-12-03       Impact factor: 4.147

3.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

4.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniors.

Authors:  David A Dorr; Spencer S Jones; Laurie Burns; Steven M Donnelly; Cherie P Brunker; Adam Wilcox; Paul D Clayton
Journal:  J Am Geriatr Soc       Date:  2006-04       Impact factor: 5.562

6.  Interpreting SF-12 mental component score: an investigation of its convergent validity with CESD-10.

Authors:  Doris S F Yu; Elsie C W Yan; Choi Kai Chow
Journal:  Qual Life Res       Date:  2015-03-19       Impact factor: 4.147

7.  Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.

Authors:  Jiseon Kim; Hyewon Chung; Robert L Askew; Ryoungsun Park; Salene M W Jones; Karon F Cook; Dagmar Amtmann
Journal:  Assessment       Date:  2016-07-28

8.  Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women.

Authors:  Kristine E Ensrud; Susan K Ewing; Brent C Taylor; Howard A Fink; Peggy M Cawthon; Katie L Stone; Teresa A Hillier; Jane A Cauley; Marc C Hochberg; Nicolas Rodondi; J Kathleen Tracy; Steven R Cummings
Journal:  Arch Intern Med       Date:  2008-02-25

9.  Monitoring population health for Healthy People 2020: evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments.

Authors:  John P Barile; Bryce B Reeve; Ashley Wilder Smith; Matthew M Zack; Sandra A Mitchell; Rosemarie Kobau; David F Cella; Cecily Luncheon; William W Thompson
Journal:  Qual Life Res       Date:  2012-08-18       Impact factor: 4.147

10.  Accelerometer-Measured Moderate to Vigorous Physical Activity and Incidence Rates of Falls in Older Women.

Authors:  David M Buchner; Eileen Rillamas-Sun; Chongzhi Di; Michael J LaMonte; Stephen W Marshall; Julie Hunt; Yuzheng Zhang; Dori E Rosenberg; I-Min Lee; Kelly R Evenson; Amy H Herring; Cora E Lewis; Marcia L Stefanick; Andrea Z LaCroix
Journal:  J Am Geriatr Soc       Date:  2017-07-29       Impact factor: 5.562

View more
  3 in total

1.  Improving outcomes for care partners of persons with traumatic brain injury: Protocol for a randomized control trial of a just-in-time-adaptive self-management intervention.

Authors:  Noelle E Carlozzi; Angelle M Sander; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Srijan Sen
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

Review 2.  Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper.

Authors:  Kah Poh Loh; Maya Abdallah; Anita J Kumar; Nina R Neuendorff; Saurabh Dahiya; Heidi D Klepin
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 4.213

3.  An App-Based Just-in-Time Adaptive Self-management Intervention for Care Partners (CareQOL): Protocol for a Pilot Trial.

Authors:  Noelle E Carlozzi; Sung Won Choi; Zhenke Wu; Jennifer A Miner; Angela K Lyden; Christopher Graves; Jitao Wang; Srijan Sen
Journal:  JMIR Res Protoc       Date:  2021-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.